Table 3. The range of CTCs detected in non-metastatic PCa patients.
No CTC | 1–5 CTCs | >5 CTCs | |
---|---|---|---|
PCa (n = 20) | 3 (15%) | 16 (80%) | 1 (5%) |
Healthy male (n = 10) | 10 (100%) | - | - |
No CTC | 1–5 CTCs | >5 CTCs | |
---|---|---|---|
PCa (n = 20) | 3 (15%) | 16 (80%) | 1 (5%) |
Healthy male (n = 10) | 10 (100%) | - | - |